The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2, two-stage study of mirvetuximab soravtansine (IMGN853) in combination with pembrolizumab in patients with microsatellite stable (MSS) endometrial cancer (EC).
 
Rebecca L. Porter
No Relationships to Disclose
 
Jennifer Taylor Veneris
Employment - Abbott Laboratories (I); GlaxoSmithKline; Takeda (I)
Stock and Other Ownership Interests - Abbvie (I)
Honoraria - Michiana Hematology Oncology
 
Nabihah Tayob
No Relationships to Disclose
 
Gabriela West
No Relationships to Disclose
 
Madeline Polak
No Relationships to Disclose
 
Jeanette Gardner
No Relationships to Disclose
 
Susana M. Campos
Honoraria - AstraZeneca; Eisai
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline
 
Carolyn N. Krasner
Research Funding - Cerulean Pharma
 
Elizabeth Katherine Lee
Research Funding - Repare Therapeutics (Inst); Seagen (Inst)
 
Joyce F. Liu
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genentech/Roche; GlaxoSmithKline; Mersana; Regeneron; Tesaro
Research Funding - 2X Oncology (Inst); Acetylon Pharmaceuticals (Inst); Agenus (Inst); Aravive (Inst); Arch Oncology (Inst); AstraZeneca (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); Regeneron (Inst); Surface Oncology (Inst); Tesaro (Inst); Vigeo Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Merck
(OPTIONAL) Uncompensated Relationships - Merck
 
Elizabeth Stover
Patents, Royalties, Other Intellectual Property - Patent pending
 
Alexi A. Wright
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - NCCN/AstraZeneca (Inst)
 
Ursula A. Matulonis
Honoraria - Advaxis
Consulting or Advisory Role - Merck; NextCure; Novartis
Research Funding - Fujifilm; Immunogen; Leap Therapeutics; Merck; Mersana; Novartis; SQZ Biotech; Syndax; Tesaro
Travel, Accommodations, Expenses - AstraZeneca
 
Panagiotis A. Konstantinopoulos
Consulting or Advisory Role - Alkermes; AstraZeneca; Bayer; Merck; Pfizer/EMD Serono; Repare Therapeutics; Tesaro; Vertex
Research Funding - AstraZeneca (Inst); Bayer (Inst); Lilly (Inst); Merck (Inst); Merck Serono (Inst); Pfizer (Inst); tesaro (Inst)